| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238005.2 |
Docetaxel |
Breast invasive carcinoma |
0.009392203 |
Resistant |
| ENSG00000238005.2 |
Docetaxel |
Sarcoma |
0.01396575 |
Resistant |
| ENSG00000238005.2 |
Docetaxel |
Colon adenocarcinoma |
0.026325958 |
Sensitive |
| ENSG00000238005.2 |
Docetaxel |
Brain lower grade glioma |
0.023618616 |
Sensitive |
